Escherichia coli UbiE86-BDO
This strain does not exhibit an improved production of the intended metabolite when compared with its closest ancestors.
Ancestors
Genotype with respect to wild type
F+ (λ) | λ- | F- λ- ilvG- rfb-50 rph-1 | fhuA2 | △frdA::FRT△pta::FRT△ldhA::FRT△adhE::FRT | 25% ubiE expression expected | Plasmid pZS‐BDO addedBars (|) indicate differences between strains.
Plasmids
-
pZS‐BDO (budABCEa)
Modifications
| Origin | Gene | Organism | Modification |
|---|---|---|---|
|
Silencing
|
|||
|
Silencing
|
|||
|
Silencing
|
|||
|
Silencing
|
|||
|
Attenuation
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Overexpression
|
Production
| Metabolites | Production type | Production | Biomass | Carbon source | Time | Scale | Ref. |
|---|---|---|---|---|---|---|---|
| (R,R)-2,3-butanediol | Titer | 2.14 g/L * | Flask | [356] |
* Inferred from plots using RetroPlot.
Heterologous.
Target metabolites are shown in bold, while non-bold metabolites represent intermediates or potential byproducts.